Volume 4 Issue 4
Survey on Glaucoma Drainage Device Usage: A United Kingdom Perspective
Tafadzwa Young-Zvandasara, MBBS, Patrick J Chiam, FRCOphth, Vanessa Palmer, BMBS, Andrew Feyi-Waboso*,FRCOphth
Systemic literature review showed that glaucoma drainage devices controls the intraocular pressure (IOP) effectively in glaucoma refractory to trabeculectomy. The use of such devices has been demonstrated to be on an upward trajectory a few years ago. Landmark studies such as the Tube Versus Trabeculectomy (TVT) study found Baerveldt implant had a higher success rate compared to trabeculectomy with mitomycin-C (MMC) when carried out in eyes with previous trabeculectomy, and/or cataract extraction with intraocular lens implantation over 5 years.
ABO and Rhesus Blood Groups and Retinoblastoma
Ouattara Y*, Kouassi-Ndjeundo JE, Koffi KV, Kouassi FX, Bilé PEFK, Diabaté Z, Konan MSMP1, Adjé YA, Sékongo L
Retinoblastoma is a high-malignity tumor in infant and child, genetically determined and developed from immature retinal cells. Indeed, tumor appearance is conditioned by occurrence of two retinoblastoma gene mutations in the RB1 gene, located on the short arm of chromosome 13, with a global incidence estimated at 1/18000 births.